Art

J-GLOBAL ID：201402222964349627   Reference number：14A1344727

Phase II study of FOLFIRINOX for chemotherapy-naethve Japanese patients with metastatic pancreatic cancer

日本人化学療法感受性転移性膵臓癌患者のFOLFIRINOX第II相試験

Author (8)： OKUSAKA Takuji (Dep. of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, JPN) ,  IKEDA Masafumi ,  FUKUTOMI Akira ,  IOKA Tatsuya ,  FURUSE Junji ,  OHKAWA Shinichi ,  ISAYAMA Hiroyuki ,  BOKU Narikazu
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 105  Issue： 10  Page： 1321-1326  Publication year： Oct. 2014 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *Malignant neoplasm of pancreatic duct metastatic ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1344727&from=J-GLOBAL&jstjournalNo=U0505A") }}

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (3)： Irinotecan ,  Leucovorin ,  Fluorouracil

Reference (17)：

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
• Japanese Ministry of Health, Labour and Welfare. Statistical investigation result. 2012: [cited 27 November 2013] Available from URL: http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei12/index.html [In Japanese].
• Center for Cancer control and Information Services, Latest Cancer Statistics. [cited 21 November 2013] Available from URL: http://ganjoho.jp/public/statistics/pub/statistics01.html [In Japanese].
• Burris HA III, Moore MJ, Anderson J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403–13.
• Moore MJ, Goldstein D, Hamm J et al. Erlotnib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the national cancer instutite of Canada Clinical Trials Group. J Clin Oncol 2007; 25: 1960–6.

Terms in the title (8)： 日本人 ,  化学療法 ,  感受性 ,  転移性 ,  膵臓癌 ,  患者 ,  FOLFIRINOX ,  第II相試験